TNFRSF10B and urinary bladder carcinoma: Notably, sulforaphane treatment counteracts this resistance in bladder cancer cells by increasing ROS production, enhancing levels of cleaved PARP, cleaved Bid, and death receptor 5 (DR5), which in turn leads to a loss of mitochondrial membrane potential (ΔΨm) and triggers apoptosis.